Biological Agents and Toxins Act FIRST TO EIGHTH SCHEDULE

Similar documents
Pathogens and toxins that are notifiable to the National Counter Terrorism Security Office. (The Anti-Terrorism, Crime and Security Act 2001)

12 Select Agents Possession, Use, or Transfer of Select Agents

Public Health Laboratory Services Branch Centre for Health Protection, Department of Health Hong Kong Special Administrative Region

2017 Georgia Biosciences Fellowship Program CALL FOR APPLICATIONS

NHSScotland Guide to the Carriage of Dangerous Goods Regulations with respect to Used Medical Devices

The Management of Biomedical Waste in Ontario

TRANSPORT SPECIMEN TRANSPORTATION INSTRUCTIONS SEPTEMBER 2014

SAMPLING AND DISPATCH OF SAMPLES

A Survey of Tier 1 BSAT Personnel Suitability and Occupational Health Programs

Who s Ready for a Bioterrorist Attack? Preparation, Biosurveillance, and Response

Guidance on regulations for the Transport of Infectious Substances

The Johns Hopkins Hospital and The Johns Hopkins University Health, Safety and Environment Manual Biological Safety:

Caltech Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern

Department of Defense Biological Safety and Security Program

Waste Management Policy

The University of Mississippi Medical Center

Microbiology Lab Practices and Safety Rules

WHY IS THIS IMPORTANT?

Recombinant protein vaccines produced in insect cells

The Rapidly Evolving Regulatory Landscape in Africa

ThinkGlobaly. ReportLocaly! HealthCareProfesional sguide. AsummaryoftheMichigan CommunicableDiseaseRules

The United States Department of Defense Biological Threat Reduction Program. Threat Agent Detection and Response and Cooperative Biological Research

In Brief IMPORTATION AND EXPORTATION OF HUMAN REMAINS AND OTHER HUMAN TISSUES

Screening of tick-borne pathogens in European ticks using High-throughput qpcr

GUIDELINES FOR THE INVESTIGATION OF ZOONOTIC DISEASE IN DOMESTIC COMPANION ANIMALS

PRINCIPLES OF INFECTIOUS DISEASE EPIDEMIOLOGY MODULE II THE INFECTIOUS DISEASE PROCESS

BioCOSHH Risk Assessment

U.S. Army Veterinary Service s Avian Influenza Playbook

Official Journal of the European Communities

UNIVERSITY OF MIAMI OFFICE OF ENVIRONMENTAL HEALTH AND SAFETY (EHS) BIOLOGICAL AGENTS REGISTRATION FORM

Biological agents The principles, design and operation of Containment Level 4 facilities

Why use passive immunity?

Sentinel Laboratory Guidelines Procedure Adopted: 5/3/2011 Nebraska Public Health Laboratory Version: December 21, 2015

Principles of Disease and Epidemiology. Copyright 2010 Pearson Education, Inc.

CHAPTER 35 HUMAN IMMUNE SYSTEM STANDARDS:SC.912.L & SC.912.L.14.6

FINAL Revised EA for the Proposed Construction and Operation of a Biosafety Level 3 Facility at LLNL

Notifiable Diseases. A Guide for Official Veterinarians

ONE HEALTH (INFECTIOUS DISEASES) POSTGRADUATE COURSES

Northeastern University Procedure for Disposal of Medical or Biological Waste

SCOPE OF ACCREDITATION TO ISO/IEC 17025:2005

Infectious Disease Antibodies and Antigens. ...Viro Stat. Supplying Researchers and Manufacturers Since

Ambulance Service Patient Care and Transportation Standards

The Approved List of biological agents

THE USE OF COST BENEFIT ANALYSIS IN ANIMAL DISEASE CONTROL,

PROCEDURE MANUAL: DAFF APPROVAL OF LABORATORIES

Infectious Disease Disasters: Bioterrorism, Emerging Infections, and Pandemics

POTENTIAL HAZARD INFORMATION & SIGNATURE SHEET

Manual for Reporting on Zoonoses, Zoonotic Agents, Antimicrobial Resistance and Food-borne Outbreaks in the framework of Directive 2003/99/EC

COMMUNICABLE DISEASE

Biohazard and Biosafety

University of Colorado Denver. Denver Anschutz Medical Campus. Regulated Medical Waste Management Plan

STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE VSCT 210 VETERINARY MICROBIOLOGY


Section III Principles of Biosafety

Animal Health key for Future Food

Surveillance System in the Philippines

Have you ever wanted to help animals and people stay healthy? Have you ever thought about working in veterinary medicine? Well, I m here to explain

Viral Antigens/Virale Antigene. SARS Proteins/SARS Proteine

Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope

WHO in 60 years: a chronology of public health milestones

Quarantine Requirements for the Importation of Laboratory Animals

Principles of infectious disease transmission

Swine Influenza Special Edition Newsletter

41 Viral rashes and skin infections

Code of Practice for the Management of Clinical Waste

High health, high performance horses: risk mitigation strategies for OIE-listed diseases

Delaware. Downloaded 01/2011

Bill Minor Ventura Foods, LLC PLANNING FOR A PANDEMIC

TRACKING EMERGING PATHOGENS IN CAMBODIA WITH ONE HEALTH PARADIGM

2 Short biographies and contact information of the workshop organizers

On ne peut commander la nature qu en lui obéissant. One can order the nature while obeying to it. Pr Mamadou GUEYE

Laboratory Reporting of Communicable Diseases Edition

Transcription:

Biological Agents and Toxins Act FIRST TO EIGHTH SCHEDULE FIRST SCHEDULE FIRST SCHEDULE BIOLOGICAL AGENTS Bacteria 1) Brucella canis Part I 2) Chlamydia psittaci (avian strains) 3) Mycobacterium canettii 4) Mycobacterium africanum 5) Mycobacterium bovis (non-bcg strains) 6) Mycobacterium microti 7) Mycobacterium tuberculosis 8) Any biological agent that is a constructed or reconstructed replication-competent form of any bacterium set out in this Part Fungi 1) Blastomyces dermatitidis 2) Histoplasma capsulatum var. capsulatum 3) Histoplasma capsulatum var. duboisii 4) Paracoccidioides brasiliensis 4A) Coccidioides immitis 4B) Coccidioides posadasii, except for the following attenuated strains: a) Δchs5; and b) Δcts2/Δard1/Δcts3 5) Any biological agent that is a constructed or reconstructed replication-competent form of any fungus set out in this Part Viruses 1) Arenaviridae a) Lymphocytic choriomeningitis virus b) Mopeia virus c) LCM-Lassa complex viruses (except Lassa virus) d) Flexal virus 2) Bunyaviridae a) Akabane virus b) California encephalitis virus c) Oropouche virus Biological Agents and Toxins Act 1

d) Hantaviruses (except Hantaan, Seoul and Sin Nombre) e) Bhanja virus f) Nairobi sheep disease virus 3) Flaviviridae a) Japanese encephalitis virus (except for the vaccine strain 14-14-2 virus) b) Murray Valley encephalitis virus c) Rocio virus d) St. Louis encephalitis virus e) Wesselsbron virus f) West Nile virus g) Louping ill virus h) Negishi virus i) Powassan virus 2) Herpesviridae a) Herpesvirus ateles 3) Orthomyxoviridae a) Dhori virus b) Thogoto virus c) Influenza A virus subtype H5N1 d) Influenza A virus subtype H7N9 4) Picornaviridae a) Poliovirus, except for the following vaccine strains: i) sabin Type-1; ii) sabin Type-2; and iii) sabin Type-3 ; 5) Reoviridae a) Orungo virus 6) Retroviridae a) Human immunodeficiency virus (HIV) Types 1 and 2 Human immunodeficiency virus (HIV) Types 1 and 2, except for any advanced generation HIV lentiviral vector, which means (i) any third or higher generation HIV vector; or (ii) any HIV vector with all of the following features: (A) comprises a minimum of 4 plasmids in total which includes all types of plasmid (e.g. packaging, structural, accessory, etc.); (B) HIV genes are split to a minimum of 2 packaging plasmids; (C) the env gene encoding for the HIV envelope is replaced; (D) the vif, vpr, vpu and nef genes are either absent or altered to be non-functional; (E) the rev and tat genes are absent, non-functional or expressed from a separate construct; and (F) the Gag and Pol genes are split over at least 2 plasmids or there is deletion in the 3'LTR or both. Vide S541/2011 wef 1 st Oct 2011 b) Human T lymphotropic virus (HTLV) Types 1 and 2 c) Simian immunodeficiency virus 7) Rhabdoviridae a) Rabies virus b) Vesicular stomatitis virus 8) Togaviridae a) Deleted by S 676/2007, wef 01/01/2008. b) Everglades virus Biological Agents and Toxins Act 2

c) Getah virus d) Mayaro virus e) Mucambo virus f) Ndumu virus g) Semliki forest virus h) Tonate virus i) Western equine encephalitis virus 9) Unconventional agents associated with the transmission of Spongiform Encephalitis a) Bovine spongiform encephalopathy prion and other related animal transmissible spongiform encephalopathy prion b) Gerstmann-Straussler-Scheinker syndrome prion c) Kuru prion d) Creutzfeldt-Jakob disease prion e) Variant Creutzfeldt-Jakob disease prion f) Fatal familial insomnia prion 10) Any biological agent that is a constructed or reconstructed replication-competent form of any virus set out in this Part Part II Bacteria 1) Bacillus anthracis, except for the attenuated strains devoid of a) plasmid px02; or b) plasmids px01 and px02 2) Brucella abortus, except for the attenuated strains a) 19; or b) RB51 3) Brucella melitensis 4) Brucella suis 5) Burkholderia mallei 6) Burkholderia pseudomallei 7) Clostridium botulinum 8) Franciscella tularensis, except for the attenuated strains of a) the subspecies of novicida (the UTAH 112 [ATCC 15482]); b) the subspecies of holartica live vaccine strain [ATCC 29684]; or c) the B38 strain [ATTC 6223] 9) Yersinia pestis, except for the attenuated strains devoid of a) Pgm locus [EV76 strain]; b) 75 kb low-calcium response virulence plasmid [Tjiwidej S strain] 10) Any biological agent that is a constructed or reconstructed replication-competent form of any bacterium set out in this Part Rickettsiae 1) Coxiella burnetii (except for the attenuated Phase II, plaque purified clone 4 of the Nine Mile strain) Biological Agents and Toxins Act 3

2) Rickettsia - all species 3) Any biological agent that is a constructed or reconstructed replication-competent form of any rickettsia set out in this Part Fungi 1) Coccidioides immitis 2) Coccidioides posadasii, except for the following attenuated strains: a. chs5; and b. cts2/ ard1/ cts3 ; 3) Any biological agent that is a constructed or reconstructed replication-competent form of any fungus set out in this Part Viruses 1) Arenaviridae a) Flexal virus 2) Bunyaviridae a) Hantaan virus b) Seoul virus c) Sin Nombre virus d) Rift Valley fever virus (except for the vaccine strain MP-12) 3) Coronaviridae a) Middle East Respiratory Syndrome Coronavirus (MERS CoV) b) Severe Acute Respiratory Syndrome Coronavirus (SARS CoV), formerly known as SARS Coronavirus 4) Flaviviridae a) Yellow fever virus (except for the vaccine strain 17-D) 2) Poxviridae a) Monkeypox virus 3) Togaviridae a) Eastern equine encephalitis virus b) Venezuelan equine encephalitis virus. 4) Any biological agent that is a constructed or reconstructed replication-competent form of any virus set out in this Part Biological Agents and Toxins Act 4

SECOND SCHEDULE SECOND SCHEDULE BIOLOGICAL AGENTS 1) Crimean-Congo haemorrhagic fever virus 2) Cercopithecine herpesvirus 1 3) Ebola virus 4) Guanarito virus 5) Hendra virus 6) Junin virus 7) Lassa fever virus 8) Machupo virus 9) Marburg virus 10) Nipah virus 11) Sabia virus 12) Tick-borne encephalitis viruses (including Central European tick-borne encephalitis virus, Far Eastern tickborne encephalitis virus, Russian spring-summer encephalitis virus, Kyasanur forest virus, Omsk haemorrhagic fever virus, with the exception of Louping ill, Negishi and Powassan viruses listed in Schedule 1) 13) Variola major (Smallpox) virus 14) Variola minor (Alastrim) virus. 15) (1918) pandemic influenza virus 15A) Lujo virus 15B) Chapare virus 16) Any biological agent that is a constructed or reconstructed replication-competent form of any biological agent set out in this Schedule THIRD SCHEDULE THIRD SCHEDULE BIOLOGICAL AGENTS Bacteria 1) Bordetella pertussis 2) Legionella all species and all Legionella-like organisms 1) Hepatitis B virus. Viruses FOURTH SCHEDULE FOURTH SCHEDULE BIOLOGICAL AGENTS Any biological agent that causes death, disease or biological malfunction in a human, other than a First Schedule biological agent or a Second Schedule biological agent. Biological Agents and Toxins Act 5

FIFTH SCHEDULE FIFTH SCHEDULE TOXINS 1) Botulinum toxins (Types A, B, C, D, E, F and G) 2) Clostridium perfringens toxins 3) Staphylococcal Enterotoxins 4) Shigatoxins 5) Verotoxins 6) T-2 toxin 7) Tetanus toxin 8) HT-2 toxin Vide S541/2011 wef 1 st Oct 2011 SIXTH SCHEDULE BIOSAFETY COMMITTEE (Section 39 (1)) Every biosafety committee appointed by an operator in relation to its facility shall comprise the following persons: a) the biosafety co-ordinator referred to in section 39 (1); b) a person having expertise in microbiology, and knowledge in the physical and biological sciences, and laboratory practices; c) a member of the staff of the operator who is in charge of maintaining the safe and proper functioning of the facility and its equipment; d) a representative from the senior management of the operator; and e) such other person (whether appointed on a permanent or an ad hoc basis) who is, in the opinion of the operator of the facility, sufficiently qualified or experienced to enable the biosafety committee to carry out its functions specified in section 39. Biological Agents and Toxins Act 6

SEVENTH SCHEDULE BIOHAZARD SIGN (Section 40 (d)) EIGHTH SCHEDULE NON-COMPOUNDABLE OFFENCES (Section 59(1)) 1) An offence under section 5 or 30 is not compoundable under section 59. Biological Agents and Toxins Act 7